Oddo BHF Asset Management Sas bought a new position in Lam Research Co. (NASDAQ:LRCX – Free Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 444 shares of the semiconductor company’s stock, valued at approximately $362,000.
Other large investors have also added to or reduced their stakes in the company. CarsonAllaria Wealth Management Ltd. purchased a new stake in shares of Lam Research in the second quarter worth approximately $32,000. RFP Financial Group LLC grew its holdings in Lam Research by 52.2% during the second quarter. RFP Financial Group LLC now owns 35 shares of the semiconductor company’s stock worth $37,000 after buying an additional 12 shares in the last quarter. Hobbs Group Advisors LLC purchased a new stake in Lam Research in the 2nd quarter valued at $40,000. MFA Wealth Advisors LLC bought a new position in Lam Research during the 2nd quarter valued at $45,000. Finally, Rosenberg Matthew Hamilton boosted its holdings in Lam Research by 24.0% during the 2nd quarter. Rosenberg Matthew Hamilton now owns 62 shares of the semiconductor company’s stock worth $66,000 after acquiring an additional 12 shares during the last quarter. Institutional investors own 84.61% of the company’s stock.
Insider Activity
In related news, CAO Christina Correia sold 647 shares of the stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $817.51, for a total value of $528,928.97. Following the sale, the chief accounting officer now owns 4,267 shares in the company, valued at approximately $3,488,315.17. This trade represents a 13.17 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.29% of the stock is owned by company insiders.
Analysts Set New Price Targets
Read Our Latest Stock Report on LRCX
Lam Research Stock Performance
Shares of LRCX stock opened at $76.26 on Friday. The firm’s 50 day moving average is $75.77 and its 200 day moving average is $85.42. The stock has a market capitalization of $98.12 billion, a P/E ratio of 24.68, a PEG ratio of 1.25 and a beta of 1.46. Lam Research Co. has a 12 month low of $68.87 and a 12 month high of $113.00. The company has a current ratio of 2.53, a quick ratio of 1.74 and a debt-to-equity ratio of 0.53.
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The semiconductor company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.81 by $0.05. Lam Research had a return on equity of 50.60% and a net margin of 26.02%. The firm had revenue of $4.17 billion during the quarter, compared to analyst estimates of $4.06 billion. During the same period last year, the company earned $6.85 earnings per share. The business’s revenue for the quarter was up 19.7% on a year-over-year basis. On average, sell-side analysts anticipate that Lam Research Co. will post 3.5 earnings per share for the current year.
Lam Research Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 8th. Stockholders of record on Wednesday, December 11th will be issued a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a dividend yield of 1.21%. The ex-dividend date is Wednesday, December 11th. Lam Research’s payout ratio is 29.77%.
About Lam Research
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Stories
- Five stocks we like better than Lam Research
- How to Choose Top Rated Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is a Secondary Public Offering? What Investors Need to Know
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is the Australian Securities Exchange (ASX)
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.